Benzinga
24 Sept 2026, 11:35 UTC · 1h ago
Verdict
Headline takes no side. We score CRWV +0.80 across three claims — strongly bullish.
+0.80strongly bullish
More positive than 86% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish · 3 new · 0 priced in
UBS initiated coverage of CoreWeave on Wednesday with a Buy rating and a $120 price target.
Newinitiated coverage on Wednesday
So whatThe target represents a ~36% upside from the current $88.11 share price.
More positive than 93% of claims this week
CoreWeave announced a new multi-year customer agreement with Harell Data to deploy its biotech platform on CoreWeave Cloud.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Newannounced Thursday
More positive than 77% of claims this week
UBS analysis indicates CoreWeave's 2027 revenue multiple is currently just 3 times.
Newinitiated coverage on Wednesday
So whatA low forward multiple relative to AI peers suggests a significant valuation gap if revenue per gigawatt continues to trend upward.
More positive than 63% of claims this week
Which stocks this story touches
More positive than 86% of ticker scores this week
The company announced a new multi-year customer agreement and received a 'Buy' rating with a $120 price target from UBS.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Seeking Alpha
3h ago
—
CRWV hasn't traded since this ran. Last close $86.90 (Sep 23); the reaction starts at the next open.
CRWV chart →
